Stratum Corneum Lipid Matrix Permeability Prediction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for assessing the permeability of the stratum corneum lipid matrix to compounds are inaccurate, relying on animal testing or QSAR models that are sensitive to data quality and statistical methods, and molecular dynamics simulations show significant discrepancies with experimental data.

Innovation Solution

A method using a computer simulation model of the stratum corneum lipid matrix, comprising ceramides, free fatty acids, and cholesterol, to predict permeability, allowing for the identification of permeability modifying agents and their effects on the matrix without relying on animal testing or statistical models.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If animal testing or QSAR models are used to assess skin permeability, then assessment can be performed, but accuracy is compromised and ethical concerns arise

Engineering Contradiction:
Improvepermeability prediction accuracyVSAvoidanimal testing harm
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent creates a computational copy of the stratum corneum lipid matrix with realistic composition and structure, allowing in silico permeability assessment that replaces animal testing while maintaining scientific validity and accuracy

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The patent replaces physical/chemical experimental methods (animal testing, in vitro permeation assays) with computational molecular dynamics simulations, substituting mechanical/biological systems with a virtual computational model

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Object-affected harmful factors

If molecular dynamics simulations are used to model stratum corneum permeability, then animal testing can be avoided, but significant discrepancies with experimental data occur

Engineering Contradiction:
Improveanimal testing harmVSAvoidpermeability prediction accuracy
Core Design Contradiction:
Object-affected harmful factorsVSMeasurement precision

Solution Approach 1:

The patent systematically adjusts critical parameters including lipid composition ratios (ceramide:cholesterol:free fatty acid = 1:1:1), water content (0.3-1.0 molecules per lipid), and molecular configurations to match experimental observations, thereby improving simulation accuracy

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs dynamic molecular simulations that capture the time-dependent behavior and fluctuations of the lipid matrix, allowing realistic representation of permeability processes while maintaining computational feasibility

Inventive Principle:
Principle #15Dynamics

3Measurement precision

If detailed molecular models are created to improve prediction accuracy, then permeability can be predicted more accurately, but computational complexity and resource requirements increase

Engineering Contradiction:
Improvepermeability prediction accuracyVSAvoidcomputational model complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent uses computationally efficient force fields and simplified interaction models that provide sufficient accuracy for permeability prediction without requiring excessive computational resources, enabling routine application

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent focuses computational effort on the most critical aspects of the lipid matrix (headgroup regions, interfacial water, key lipid-lipid interactions) while using simplified representations for less critical regions, optimizing the accuracy-computation trade-off

Inventive Principle:
Principle #16Partial or excessive action

Data Source

PatentUS11682473B2Skin permeability prediction
Publication Date: 2023.06.20 ERCO PHARMA AB
  • US11682473B2 patent drawing
  • US11682473B2 patent drawing
  • US11682473B2 patent drawing

AI summary

The present disclosure relates to a method for predicting the permeability of a stratum corneum lipid matrix to a compound. The method includes providing a model of the stratum corneum lipid matrix including ceramides, free fatty acids, cholesterol and water. The model includes 25-45% total ceramides, based on the molar concentration of all components except water, whereof more than 90% are in extended configuration, and wherein 0-30% of the total ceramides are O-acyl ceramides and 100-70% of the total ceramides are non-O-acyl ceramides. The model also includes 25-45% fatty acid and 25-40% of cholesterol, wherein 1-40% of the cholesterol is located by the fatty acid moeity of the ceramides, and 0.2-6 water molecules per ceramide molecule. The method includes providing molecular designators of the compound and calculating, via means of computer simulations, the predicted permeability using the model and the molecular designators.